Literature DB >> 2648237

Complications of cataract extraction with intraocular lens implantation.

D F Goodman1, W J Stark, J D Gottsch.   

Abstract

Due to continued improvement in lens design, lens manufacturing, and surgical technique, the incidence of complications of cataract surgery with intraocular lens (IOL) implantation have decreased in recent years. Complications may be categorized into operative and postoperative, both early and late onset. Operative complications include posterior capsule rupture with or without vitreous loss, loss of all or part of the lens nucleus, iris damage, and stripping of Descemet's membrane. Early postoperative complications include pupillary block, hyphema, elevation of the intraocular pressure associated with the use of viscoelastic substances, persistent uveitis with or without hypopyon, and endophthalmitis. Late postoperative complications include IOL malposition, secondary glaucoma, cystoid macular edema, retinal detachment, and pseudophakic bullous keratopathy.

Entities:  

Mesh:

Year:  1989        PMID: 2648237

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  10 in total

1.  Comparative study measuring the dilatory effect of a mydriatic device (Mydriasert(®)) versus topical drops.

Authors:  Manuel Saenz-de-Viteri; Patricia Fernández-Robredo; Elisa de Nova; Elvira Bonet-Farriol; Alfonso L Sabater; Javier Zarranz-Ventura; Josemaria Caire; Luis M Sádaba; Angel Salinas-Alamán; Alfredo García-Layana
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

2.  Comparison of the effects of 1/10,000 and 1/100,000 concentrations of intracameral epinephrine on corneal endothelium and macular thickness after uncomplicated phacoemulsification.

Authors:  Shahram Bamdad; Mohammad Reza Khalili; Reza Rahimi
Journal:  Eye (Lond)       Date:  2020-03-03       Impact factor: 3.775

3.  [Iritis with destabilization of the intraocular pressure due to dislocation of a posterior chamber intraocular lens].

Authors:  D M Handzel
Journal:  Ophthalmologe       Date:  2012-04       Impact factor: 1.059

4.  Comparison of Ketorolac Tromethamine and Prednisolone Acetate in Preventing Surgically Induced Miosis during Cataract Surgery.

Authors:  Yusuf M Suleiman; Najwa F Krdoghli; Aksam J Ahmad
Journal:  Sultan Qaboos Univ Med J       Date:  2010-04-17

5.  Cystoid macular oedema after extracapsular cataract extraction and intraocular lens implantation in diabetic patients without retinopathy.

Authors:  U Menchini; F Bandello; R Brancato; F I Camesasca; M Galdini
Journal:  Br J Ophthalmol       Date:  1993-04       Impact factor: 4.638

6.  Intraocular adrenaline maintains mydriasis during cataract surgery.

Authors:  M C Corbett; A B Richards
Journal:  Br J Ophthalmol       Date:  1994-02       Impact factor: 4.638

7.  Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: a prospective randomised multicentre study.

Authors:  A Heiligenhaus; B Steinmetz; R Lapuente; P Krallmann; C Althaus; W K Steinkamp; B Dick
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

8.  Pupil Dilation with Intracameral Epinephrine Hydrochloride during Phacoemulsification and Intraocular Lens Implantation.

Authors:  A-Yong Yu; Hua Guo; Qin-Mei Wang; Fang-Jun Bao; Jing-Hai Huang
Journal:  J Ophthalmol       Date:  2016-01-20       Impact factor: 1.909

9.  Pharmacologic interventions for mydriasis in cataract surgery.

Authors:  Mustafa Iftikhar; Samuel A Abariga; Barbara S Hawkins; Sidra Zafar; Tahreem A Mir; Henry Jampel; Fasika A Woreta
Journal:  Cochrane Database Syst Rev       Date:  2021-05-27

10.  Intracameral phenylephrine and ketorolac injection (OMS302) for maintenance of intraoperative pupil diameter and reduction of postoperative pain in intraocular lens replacement with phacoemulsification.

Authors:  Richard L Lindstrom; James C Loden; Thomas R Walters; Steven H Dunn; J Steven Whitaker; Terry Kim; Gregory A Demopulos; Khiun Tjia
Journal:  Clin Ophthalmol       Date:  2014-09-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.